Q4 2021 Regulus Therapeutics Inc Earnings Call Transcript

Mar 10, 2022 / 10:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Regulus Therapeutics Q4 2021 Conference Call. (Operator Instructions)

I would now like to turn the call over to your host, Cris Calsada. You may begin.

Cris Calsada -

Thank you, operator. Good afternoon, and thank you for joining us to discuss Regulus Therapeutics' fourth quarter and full year 2021 financial results and corporate highlights. With me on today's call Jay Hagan, President and Chief Executive Officer; and Dr. Denis Drygin, Chief Scientific Officer. Jay will provide opening remarks and share progress on our ADPKD program, and I will review the financial results before we open the line for questions.

Before we begin, I would like to remind that this call will contain forward-looking statements concerning Regulus Therapeutics' future expectations, plans, prospects, corporate strategy and performance, which constitute forward-looking statements for the purpose of the safe harbor provision under the Private Securities Litigation Reform Act of 1995. Actual results may differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot